echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Nat Commun: Scientists are hoping to develop new treatments for malaria.

    Nat Commun: Scientists are hoping to develop new treatments for malaria.

    • Last Update: 2020-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    11, 2020 // In a recent study published in the international journal Nature Communications, scientists from the Australian National University and others have developed a new treatment to treat malaria, which is resistant to drugs, and that it also enhances the therapeutic effectiveness of current drugs.
    image source: Australian National University malaria is caused by the malaria parasite, mainly through the bite of infected mosquitoes to humans, the researchers say, the malaria parasite is evolving to develop some resistance to current drugs, which may be a major threat to effective control and elimination of malaria, in the article, the researchers focused on a protein called PfCRT, which is critical to the generation of malaria parasite strains, but also a potential new drug target. 'For nearly 20 years, scientists from around the world have been delving into the function of pfCRT proteins and why they are critical to the survival of the malaria parasite,' said Martin, a researcher at
    .
    researchers say the pfCRT protein can be suppressed by drugs, suggesting that the natural function of PfCRT may be a potential target for drug development, and could also help develop new treatments that clarify the function of the PfCRT protein or help researchers develop new therapies that effectively block the protein's function and inhibit the spread of malaria.
    in addition to directly killing malaria parasites, these targeted drugs can also be used in combination therapy to eliminate the multiple resistance induced by the PfCRT protein and restore the activity of existing drugs.
    the treatment of malaria parasites targeted in a variety of ways is critical to effectively combating the spread of multi-drug-resistant malaria; researchers are now able to gain insight into the reasons and constraints that determine the evolution of PfCRT proteins in different malaria-endemic regions of the world; and the latest global malaria report shows that there will be 228 million malaria patients worldwide in 2018 and about 405,000 people will die from malaria infections, forcing scientists to develop in-depth research to combat malaria treatments.
    () Originals: Shafik, S.H., Cobbold, S.A., Barkat, K. et al. The natural function of the malaria-up's chloroquine resistance transporter. Nat Commun 11, 3922 (2020). doi: 10.1038/s41467-020-17781-6.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.